Athenex Inc.

4.10-0.1900-4.43%Vol 1.21M1Y Perf -51.46%
Apr 9th, 2021 16:00 DELAYED
BID4.09 ASK4.10
Open4.25 Previous Close4.29
Pre-Market- After-Market-
 - -  - -%
Target Price
11.40 
Analyst Rating
Strong Buy 1.20
Potential %
178.05 
Finscreener Ranking
★★★★     53.67
Insiders Trans % 3/6/12 mo.
-33/43/86 
Value Ranking
★+     45.37
Insiders Value % 3/6/12 mo.
-97/-86/-25 
Growth Ranking
★★     48.17
Insiders Shares Cnt. % 3/6/12 mo.
-97/-92/-60 
Income Ranking
 —    -
Market Cap383.17M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
1.50 
Earnings Date
6th May 2021

Today's Price Range

4.074.28

52W Range

3.9315.24

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-6.82%
1 Month
-12.95%
3 Months
-64.81%
6 Months
-66.50%
1 Year
-51.46%
3 Years
-77.20%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ATNX4.10-0.1900-4.43
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
3.70
4.70
0.46
0.88
-11.90
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
34.00
-68.80
-66.10
-228.30
-79.98
RevenueValueIndustryS&P 500US Markets
97.46M
1.04
25.16
44.59
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.42-0.53-26.19
Q03 2020-0.46-0.444.35
Q02 2020-0.31-0.41-32.26
Q01 2020-0.21-0.24-14.29
Q04 2019-0.50-0.2844.00
Q03 2019-0.46-0.452.17
Q02 2019-0.44-0.440.00
Q01 2019-0.45-0.53-17.78
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.3721.28Positive
6/2021 QR-0.3719.57Positive
12/2021 FY-1.283.03Positive
12/2022 FY-1.16-176.19Negative
Next Report Date6th May 2021
Estimated EPS Next Report-0.37
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume1.21M
Shares Outstanding93.46M
Trades Count7.97K
Dollar Volume21.94M
Avg. Volume2.86M
Avg. Weekly Volume1.54M
Avg. Monthly Volume2.70M
Avg. Quarterly Volume3.02M

Athenex Inc. (NASDAQ: ATNX) stock closed at 4.1 per share at the end of the most recent trading day (a -4.43% change compared to the prior day closing price) with a volume of 1.21M shares and market capitalization of 383.17M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 581 people. Athenex Inc. CEO is Johnson Y.N. Lau.

The one-year performance of Athenex Inc. stock is -51.46%, while year-to-date (YTD) performance is -62.93%. ATNX stock has a five-year performance of %. Its 52-week range is between 3.93 and 15.24, which gives ATNX stock a 52-week price range ratio of 1.50%

Athenex Inc. currently has a PE ratio of -2.50, a price-to-book (PB) ratio of 2.24, a price-to-sale (PS) ratio of 4.34, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -40.51%, a ROC of -39.73% and a ROE of -76.00%. The company’s profit margin is -79.98%, its EBITDA margin is -66.10%, and its revenue ttm is $97.46 Million , which makes it $1.04 revenue per share.

Of the last four earnings reports from Athenex Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.37 for the next earnings report. Athenex Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Athenex Inc. is Strong Buy (1.2), with a target price of $11.4, which is +178.05% compared to the current price. The earnings rating for Athenex Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Athenex Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Athenex Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 30.74, ATR14 : 0.96, CCI20 : -100.40, Chaikin Money Flow : -0.43, MACD : -2.24, Money Flow Index : 13.96, ROC : -61.56, RSI : 18.20, STOCH (14,3) : 7.24, STOCH RSI : 1.00, UO : 18.09, Williams %R : -92.76), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Athenex Inc. in the last 12-months were: Jeffrey Yordon (Option Excercise at a value of $199 980), Jinn Wu (Buy at a value of $333 500), Jinn Wu (Sold 98 000 shares of value $465 500 ), Johnson Y.N. Lau (Buy at a value of $557 676), Johnson Y.N. Lau (Option Excercise at a value of $364 000), Jordan Kanfer (Buy at a value of $5 171), Kim Campbell (Buy at a value of $36 465), Manson Fok (Buy at a value of $335 763), Randoll Sze (Buy at a value of $11 400), Rudolf Kwan (Buy at a value of $12 820), Stephanie Davis (Buy at a value of $113 500), William Zuo (Sold 419 931 shares of value $1 898 088 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.20
Strong Buy
1.20
Strong Buy
1.20

Athenex Inc.

Athenex Inc is a global biopharmaceutical company. It is dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer. The company's operating segment includes the Oncology Innovation Platform; Global Supply Chain Platform and Commercial Platform. It generates maximum revenue from the Commercial Platform segment. Commercial Platform segment includes APD, which focuses on the manufacturing, distribution, and sales of specialty pharmaceuticals. Geographically, it derives a majority of revenue from the United States and also has a presence in Spain; Austria; India; China; the United Kingdom and Other foreign countries.

CEO: Johnson Y.N. Lau

Telephone: +1 716 427-2950

Address: 1001 Main Street, Buffalo 14203, NY, US

Number of employees: 581

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

52%48%

Bearish Bullish

46%54%

News

Stocktwits